Table 6.

Effects of TFR on the thymus, spleen path morphology in the mice perimenopausal model ($\overline{\text{x}}$ ± s, n = 12).

Group	Dose (mg/kg)	Thymic cortex thickness (μm)	Splenic nodule (μm)
Blank group	–	337.94 ± 26.16**	427.88 ± 58.96**
Model group	–	215.51 ± 28.11	261.52 ± 33.22
GNA capsule group	675	364.53 ± 36.82**	381.28 ± 59.62**
SIS capsule group	250	321.42 ± 66.84**	340.71 ± 52.41**
TFR high-dose group	200	285.96 ± 42.13**	324.13 ± 35.51**
TFR mid-dose group	100	271.46 ± 37.77*	285.24 ± 25.81
TFR low-dose group	50	279.91 ± 58.15	257.07 ± 27.90

Note: Compared with the model group.

^*P < 0.05.

^**P < 0.01.